JSERX
Price
$49.99
Change
+$0.26 (+0.52%)
Updated
Jul 31 closing price
Net Assets
2.68B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

JSERX vs VSMAX

JSERX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
JSERX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSERX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. JSERX (2.68B). VSMAX pays higher dividends than JSERX: VSMAX (1.21) vs JSERX (0.40). JSERX was incepted earlier than VSMAX: JSERX (20 years) vs VSMAX (26 years). JSERX (0.84) is less costly to investors than VSMAX (0.05). JSERX is a more actively managed with annual turnover of: 52.00 vs. VSMAX (17.00). JSERX has a lower initial minimum investment than VSMAX: JSERX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. JSERX (-6.85). VSMAX return over 5 years is better than : 35.11 vs. JSERX (-34.49).
JSERXVSMAXJSERX / VSMAX
Total Expense Ratio0.800.051,600%
Annual Report Gross Expense Ratio0.840.051,680%
Fund Existence20 years26 years-
Gain YTD10.64614.58873%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.68B189B1%
Annual Yield % from dividends0.401.2133%
Returns for 1 year-6.8522.58-30%
Returns for 3 years-7.8543.42-18%
Returns for 5 years-34.4935.11-98%
Returns for 10 years6.74155.964%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H